Course: Advanced Melanoma: Optimizing ICI-Based Therapies
CME Credits: 0.75
Released: 2024-11-22
Patients with advanced melanoma face rapid disease progression and require complex treatments. This educational program delves into the latest in immune checkpoint inhibitors (ICIs), which offer improved survival rates and new hope. Through updates on the latest data and real-world case studies, participants will learn to apply emerging evidence to personalized ICI-based treatment plans for BRAF-mutant and wild-type melanoma.
Upon completion of this activity, participants should be able to:
View Full Course